• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫组织化学标志物和组织学分类对恶性犬乳腺肿瘤的预后意义。

Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.

机构信息

Veterinary Teaching Hospital, University of Extremadura, Cáceres, Spain.

Animal Medicine and Surgery Unit, Department of Animal Medicine, Faculty of Veterinary Medicine, University of Extremadura, Cáceres, Spain.

出版信息

Vet Comp Oncol. 2020 Dec;18(4):753-762. doi: 10.1111/vco.12603. Epub 2020 May 22.

DOI:10.1111/vco.12603
PMID:32336005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7754150/
Abstract

Canine mammary carcinoma represents a model for the study of human breast cancer, although the prognostic value of various clinical, histological and immunohistochemical parameters has shown contradictory results. A prospective study, through a 4-year follow-up, was performed in 77 patients with mammary carcinoma to analyse the association between histological diagnosis, grade of malignancy, peritumoral and vascular invasion. We have also performed immunohistochemistry for the expression of oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and cyclooxygenase-2 (COX-2) that define human biomarkers of disease progression and treatment response. An association between histological diagnosis and clinical stage was observed with a high proportion of complex carcinoma classified as stage I. There was a higher proportion of ER /PR /HER2 tumours in stage I. In contrast, triple-negative tumours (ER /PR /HER2 ) were found mainly in advanced clinical stages and were associated with vascular and peritumoral invasion. The tumours included in group VII (carcinosarcoma/adenosquamous carcinoma/other special types of carcinoma) had a higher expression of COX-2. The univariate analysis showed that those patients with complex carcinoma had the lowest incidence of metastases and the highest probability of survival. In contrast, a high proportion of patients with anaplastic/inflammatory carcinoma developed metastases and showed the lowest probability of survival. In addition, the estimated survival time was shorter for those patients with triple-negative tumours and those with high COX-2 expression. However, in the multivariate analysis, only the peritumoral invasion maintained its prognostic significance. In conclusion, in our study anaplastic/inflammatory carcinomas had the worst prognosis with a high proportion of triple-negative tumours in this category.

摘要

犬乳腺肿瘤是研究人类乳腺癌的模型,尽管各种临床、组织学和免疫组织化学参数的预后价值显示出相互矛盾的结果。通过 4 年的随访,对 77 例乳腺肿瘤患者进行了一项前瞻性研究,分析了组织学诊断、恶性程度、肿瘤周围和血管浸润之间的关系。我们还进行了雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体 2(HER2)和环氧化酶-2(COX-2)的免疫组织化学表达分析,这些标志物可以定义疾病进展和治疗反应的人类生物标志物。观察到组织学诊断与临床分期之间存在关联,复杂癌的比例较高,被归类为 I 期。I 期 ER / PR / HER2 肿瘤比例较高。相反,三阴性肿瘤(ER / PR / HER2)主要出现在晚期临床阶段,与血管和肿瘤周围浸润有关。归入 VII 组(癌肉瘤/腺鳞癌/其他特殊类型的癌)的肿瘤 COX-2 表达较高。单因素分析显示,复杂癌患者转移发生率最低,生存概率最高。相反,比例较高的间变性/炎性癌患者发生转移,生存概率最低。此外,三阴性肿瘤和 COX-2 高表达患者的估计生存时间较短。然而,在多因素分析中,只有肿瘤周围浸润保持其预后意义。总之,在我们的研究中,间变性/炎性癌的预后最差,此类肿瘤中三阴性肿瘤的比例较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/7754150/72b2c4b73d84/VCO-18-753-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/7754150/c4164ff9dfc2/VCO-18-753-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/7754150/535e8a4e0f50/VCO-18-753-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/7754150/31bfecb932f4/VCO-18-753-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/7754150/72b2c4b73d84/VCO-18-753-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/7754150/c4164ff9dfc2/VCO-18-753-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/7754150/535e8a4e0f50/VCO-18-753-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/7754150/31bfecb932f4/VCO-18-753-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/7754150/72b2c4b73d84/VCO-18-753-g004.jpg

相似文献

1
Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.免疫组织化学标志物和组织学分类对恶性犬乳腺肿瘤的预后意义。
Vet Comp Oncol. 2020 Dec;18(4):753-762. doi: 10.1111/vco.12603. Epub 2020 May 22.
2
Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.评估激素受体表达以预测患有恶性乳腺肿瘤的雌性犬的生存情况。
J Am Vet Med Assoc. 2009 Aug 15;235(4):391-6. doi: 10.2460/javma.235.4.391.
3
Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.使用四种基底标志物鉴定三阴性和基底样犬乳腺癌
J Comp Pathol. 2013 May;148(4):298-306. doi: 10.1016/j.jcpa.2012.08.009. Epub 2012 Oct 15.
4
Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.完整和去卵巢犬乳腺肿瘤亚型中雌激素和孕激素受体的表达
Vet J. 2014 Oct;202(1):62-8. doi: 10.1016/j.tvjl.2014.06.003. Epub 2014 Jun 11.
5
The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.Cox-2 表达在犬恶性乳腺肿瘤预后中的作用。
Res Vet Sci. 2010 Jun;88(3):441-5. doi: 10.1016/j.rvsc.2009.10.009. Epub 2009 Nov 25.
6
MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.犬恶性乳腺肿瘤中 MUC1 的表达及其与临床病理特征的关系。
Vet J. 2009 Dec;182(3):491-3. doi: 10.1016/j.tvjl.2008.09.007. Epub 2008 Oct 22.
7
Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.犬乳腺中维生素D受体的表达及其与临床病理参数和孕激素/雌激素受体的关系。
Vet Comp Oncol. 2018 Mar;16(1):E185-E193. doi: 10.1111/vco.12371. Epub 2017 Nov 27.
8
Expression and prognostic significance of CK19 in canine malignant mammary tumours.犬恶性乳腺肿瘤中 CK19 的表达及预后意义。
Vet J. 2010 Apr;184(1):45-51. doi: 10.1016/j.tvjl.2009.02.001. Epub 2009 Mar 4.
9
Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.正常、发育异常及肿瘤性犬猫乳腺组织中类固醇受体表达的比较。
Res Vet Sci. 2005 Dec;79(3):225-32. doi: 10.1016/j.rvsc.2005.02.002. Epub 2005 Apr 7.
10
Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours.环氧化酶-2与表皮生长因子受体在犬恶性乳腺肿瘤中的共表达
J Comp Pathol. 2014 Jan;150(1):27-34. doi: 10.1016/j.jcpa.2013.07.005. Epub 2013 Sep 21.

引用本文的文献

1
The Number and Size of Invasion Areas in Mixed-Type Carcinoma in Female Dogs Are Associated with Regional Metastases.雌性犬混合型癌侵袭区域的数量和大小与区域转移相关。
Vet Sci. 2025 Mar 31;12(4):318. doi: 10.3390/vetsci12040318.
2
Low-Invasive Biomarkers of Canine Mammary Tumours.犬乳腺肿瘤的低侵入性生物标志物
Vet Med Sci. 2025 Mar;11(2):e70280. doi: 10.1002/vms3.70280.
3
Differential somatic coding variant landscapes between laser microdissected luminal epithelial cells from canine mammary invasive ductal solid carcinoma and comedocarcinoma.

本文引用的文献

1
Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.犬乳腺肿瘤:生存研究中分类与分级方法的比较
Vet Pathol. 2019 Mar;56(2):208-219. doi: 10.1177/0300985818806968. Epub 2018 Oct 31.
2
Comparative aspects of canine and human inflammatory breast cancer.犬与人炎性乳腺癌的比较方面。
Semin Oncol. 2017 Aug;44(4):288-300. doi: 10.1053/j.seminoncol.2017.10.012. Epub 2018 Jan 19.
3
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
犬乳腺浸润性导管实性癌和粉刺癌的激光显微切割管腔上皮细胞之间的体细胞编码变异景观差异
BMC Cancer. 2024 Dec 18;24(1):1524. doi: 10.1186/s12885-024-13239-w.
4
Immunohistochemistry Screening of Different Tyrosine Kinase Receptors in Canine Solid Tumors-Part I: Proposal of a Receptor Panel to Predict Therapies.免疫组织化学筛选犬类实体肿瘤中的不同酪氨酸激酶受体-第 I 部分:预测治疗的受体面板建议。
Int J Mol Sci. 2024 Aug 2;25(15):8438. doi: 10.3390/ijms25158438.
5
To study the utility of COX-2 as immunohistochemical prognostic marker in comparison to various histopathological parameters and TNM staging in breast carcinoma: an observational, cross-sectional study protocol.为了研究与各种组织病理学参数和TNM分期相比,COX-2作为免疫组织化学预后标志物在乳腺癌中的效用:一项观察性横断面研究方案。
F1000Res. 2024 Jun 18;12:1057. doi: 10.12688/f1000research.138776.2. eCollection 2023.
6
Contribution of non-steroidal anti-inflammatory drugs to breast cancer treatment: and studies.非甾体抗炎药在乳腺癌治疗中的作用:及研究。 (注:原文中“and studies”前似乎缺少内容,翻译可能不太准确,建议提供更完整准确的原文。)
Vet World. 2024 May;17(5):1052-1072. doi: 10.14202/vetworld.2024.1052-1072. Epub 2024 May 15.
7
Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland.波兰单中心回顾性研究中雌性犬乳腺肿瘤的风险因素分析及临床病理特征。
Sci Rep. 2024 Mar 6;14(1):5569. doi: 10.1038/s41598-024-56194-z.
8
Mammary Glands of Women, Female Dogs and Female Rats: Similarities and Differences to Be Considered in Breast Cancer Research.女性、雌性犬类和雌性大鼠的乳腺:乳腺癌研究中需考虑的异同
Vet Sci. 2023 May 30;10(6):379. doi: 10.3390/vetsci10060379.
9
Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99.犬乳腺肿瘤诱导外周血 CD20、CD45RA 和 CD99 水平的变化。
Int J Mol Sci. 2023 May 25;24(11):9222. doi: 10.3390/ijms24119222.
10
Associations Between Dog Breed and Clinical Features of Mammary Epithelial Neoplasia in Bitches: an Epidemiological Study of Submissions to a Single Diagnostic Pathology Centre Between 2008-2021.犬种与母犬乳腺上皮肿瘤临床特征的相关性:2008-2021 年间单一诊断病理学中心提交病例的流行病学研究。
J Mammary Gland Biol Neoplasia. 2023 Mar 24;28(1):6. doi: 10.1007/s10911-023-09531-3.
犬浸润性乳腺肿瘤作为人类乳腺癌模型。第 1 部分:自然病史和预后因素。
Breast Cancer Res Treat. 2018 Feb;167(3):635-648. doi: 10.1007/s10549-017-4548-2. Epub 2017 Oct 30.
4
Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.犬浸润性乳腺肿瘤作为人类乳腺癌模型。第 2 部分:免疫表型和预后意义。
Breast Cancer Res Treat. 2018 Jan;167(2):459-468. doi: 10.1007/s10549-017-4542-8. Epub 2017 Oct 23.
5
Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.诱导型一氧化氮合酶、环氧化酶-2和血管内皮生长因子在犬乳腺肿瘤及非肿瘤性乳腺组织中的表达:与临床病理特征及肿瘤分级的相关性
Acta Vet Hung. 2017 Sep;65(3):382-393. doi: 10.1556/004.2017.036.
6
Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.犬乳腺肿瘤组织学亚型的预后意义:一项对229例病例的观察性队列研究
Vet Pathol. 2017 Jul;54(4):571-578. doi: 10.1177/0300985817698208. Epub 2017 Mar 29.
7
HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.HER-2、EGFR、Cox-2和Ki67在犬乳腺癌淋巴结转移中的表达:与临床病理参数及总生存期的关联
Res Vet Sci. 2016 Jun;106:121-30. doi: 10.1016/j.rvsc.2016.03.020. Epub 2016 Apr 7.
8
Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?通过基于抗体、转录组学和质谱分析研究犬乳腺肿瘤中HER2的表达:狗是否是人类乳腺癌的合适动物模型?
Tumour Biol. 2015 Nov;36(11):9083-91. doi: 10.1007/s13277-015-3661-2. Epub 2015 Jun 19.
9
Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem.2002年至2012年期间诊断出的雌性犬乳腺肿瘤的流行病学研究:一个日益严重的动物健康问题。
PLoS One. 2015 May 18;10(5):e0127381. doi: 10.1371/journal.pone.0127381. eCollection 2015.
10
Biomarkers for Basal-like Breast Cancer.基底样乳腺癌的生物标志物。
Cancers (Basel). 2010 May 28;2(2):1040-65. doi: 10.3390/cancers2021040.